Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Total Debt (2020)

Historic Total Debt for Vistagen Therapeutics (VTGN) over the last 4 years, with Q3 2020 value amounting to $87300.0.

  • Vistagen Therapeutics' Total Debt changed N/A to $87300.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $87300.0, marking a year-over-year change of. This contributed to the annual value of $3600.0 for FY2013, which is N/A changed from last year.
  • Latest data reveals that Vistagen Therapeutics reported Total Debt of $87300.0 as of Q3 2020.
  • Over the past 5 years, Vistagen Therapeutics' Total Debt peaked at $124700.0 during Q2 2020, and registered a low of $87300.0 during Q3 2020.